69 related articles for article (PubMed ID: 8765504)
1. (S)-(-)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine maleate (SIB-1508Y): a novel anti-parkinsonian agent with selectivity for neuronal nicotinic acetylcholine receptors.
Cosford ND; Bleicher L; Herbaut A; McCallum JS; Vernier JM; Dawson H; Whitten JP; Adams P; Chavez-Noriega L; Correa LD; Crona JH; Mahaffy LS; Menzaghi F; Rao TS; Reid R; Sacaan AI; Santori E; Stauderman KA; Whelan K; Lloyd GK; McDonald IA
J Med Chem; 1996 Aug; 39(17):3235-7. PubMed ID: 8765504
[No Abstract] [Full Text] [Related]
2. Expedient five-step synthesis of SIB-1508Y from natural nicotine.
Wagner FF; Comins DL
J Org Chem; 2006 Oct; 71(22):8673-5. PubMed ID: 17064057
[TBL] [Abstract][Full Text] [Related]
3. Effects of SIB-1508Y, a novel neuronal nicotinic acetylcholine receptor agonist, on motor behavior in parkinsonian monkeys.
Schneider JS; Pope-Coleman A; Van Velson M; Menzaghi F; Lloyd GK
Mov Disord; 1998 Jul; 13(4):637-42. PubMed ID: 9686767
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of (S)-(2)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine HCl (SIB-1508Y, Altinicline), a novel nicotinic acetylcholine receptor agonist.
Rao TS; Adams PB; Correa LD; Santori EM; Sacaan AI; Reid RT; Cosford ND
Brain Res; 2008 Oct; 1234():16-24. PubMed ID: 18692487
[TBL] [Abstract][Full Text] [Related]
5. Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors.
Holladay MW; Wasicak JT; Lin NH; He Y; Ryther KB; Bannon AW; Buckley MJ; Kim DJ; Decker MW; Anderson DJ; Campbell JE; Kuntzweiler TA; Donnelly-Roberts DL; Piattoni-Kaplan M; Briggs CA; Williams M; Arneric SP
J Med Chem; 1998 Feb; 41(4):407-12. PubMed ID: 9484491
[TBL] [Abstract][Full Text] [Related]
6. 4-[[2-(1-Methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A): a novel cognitive enhancer with selectivity for neuronal nicotinic acetylcholine receptors.
Vernier JM; El-Abdellaoui H; Holsenback H; Cosford ND; Bleicher L; Barker G; Bontempi B; Chavez-Noriega L; Menzaghi F; Rao TS; Reid R; Sacaan AI; Suto C; Washburn M; Lloyd GK; McDonald IA
J Med Chem; 1999 May; 42(10):1684-6. PubMed ID: 10346920
[No Abstract] [Full Text] [Related]
7. 5-substituted derivatives of 6-halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-halogeno-3-((2-(S)-pyrrolidinyl)methoxy)pyridine with low picomolar affinity for alpha4beta2 nicotinic acetylcholine receptor and wide range of lipophilicity: potential probes for imaging with positron emission tomography.
Zhang Y; Pavlova OA; Chefer SI; Hall AW; Kurian V; Brown LL; Kimes AS; Mukhin AG; Horti AG
J Med Chem; 2004 May; 47(10):2453-65. PubMed ID: 15115389
[TBL] [Abstract][Full Text] [Related]
8. 5-I A-85380 and TC-2559 differentially activate heterologously expressed alpha4beta2 nicotinic receptors.
Zwart R; Broad LM; Xi Q; Lee M; Moroni M; Bermudez I; Sher E
Eur J Pharmacol; 2006 Jun; 539(1-2):10-7. PubMed ID: 16674940
[TBL] [Abstract][Full Text] [Related]
9. Effects of the nicotinic acetylcholine receptor agonist SIB-1508Y on object retrieval performance in MPTP-treated monkeys: comparison with levodopa treatment.
Schneider JS; Van Velson M; Menzaghi F; Lloyd GK
Ann Neurol; 1998 Mar; 43(3):311-7. PubMed ID: 9506547
[TBL] [Abstract][Full Text] [Related]
10. Novel pyridyl ring C5 substituted analogues of epibatidine and 3-(1-methyl-2(S)-pyrrolidinylmethoxy)pyridine (A-84543) as highly selective agents for neuronal nicotinic acetylcholine receptors containing beta2 subunits.
Wei ZL; Xiao Y; Yuan H; Baydyuk M; Petukhov PA; Musachio JL; Kellar KJ; Kozikowski AP
J Med Chem; 2005 Mar; 48(6):1721-4. PubMed ID: 15771418
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationships of pyridine-modified analogs of 3-[2-((S)-pyrrolidinyl)methoxy]pyridine, A-84543, a potent nicotinic acetylcholine receptor agonist.
Lin NH; Gunn DE; Li Y; He Y; Bai H; Ryther KB; Kuntzweiler T; Donnelly-Roberts DL; Anderson DJ; Campbell JE; Sullivan JP; Arneric SP; Holladay MW
Bioorg Med Chem Lett; 1998 Feb; 8(3):249-54. PubMed ID: 9871663
[TBL] [Abstract][Full Text] [Related]
12. Incorporation of the beta3 subunit has a dominant-negative effect on the function of recombinant central-type neuronal nicotinic receptors.
Broadbent S; Groot-Kormelink PJ; Krashia PA; Harkness PC; Millar NS; Beato M; Sivilotti LG
Mol Pharmacol; 2006 Oct; 70(4):1350-7. PubMed ID: 16822928
[TBL] [Abstract][Full Text] [Related]
13. Nicotinic acetylcholine receptor agonist SIB-1508Y improves cognitive functioning in chronic low-dose MPTP-treated monkeys.
Schneider JS; Tinker JP; Van Velson M; Menzaghi F; Lloyd GK
J Pharmacol Exp Ther; 1999 Aug; 290(2):731-9. PubMed ID: 10411585
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological characterization of nicotinic acetylcholine receptor properties of (+)- and (-)-pyrido-[3,4-b]homotropanes.
Carroll FI; Hu X; Navarro HA; Deschamps J; Abdrakhmanova GR; Damaj MI; Martin BR
J Med Chem; 2006 Jun; 49(11):3244-50. PubMed ID: 16722642
[TBL] [Abstract][Full Text] [Related]
15. Chemistry and Pharmacology of a Series of Unichiral Analogues of 2-(2-Pyrrolidinyl)-1,4-benzodioxane, Prolinol Phenyl Ether, and Prolinol 3-Pyridyl Ether Designed as α4β2-Nicotinic Acetylcholine Receptor Agonists.
Bolchi C; Valoti E; Gotti C; Fasoli F; Ruggeri P; Fumagalli L; Binda M; Mucchietto V; Sciaccaluga M; Budriesi R; Fucile S; Pallavicini M
J Med Chem; 2015 Aug; 58(16):6665-77. PubMed ID: 26225816
[TBL] [Abstract][Full Text] [Related]
16. Modulation of neuronal nicotinic acetylcholine receptors by mercury.
Mirzoian A; Luetje CW
J Pharmacol Exp Ther; 2002 Aug; 302(2):560-7. PubMed ID: 12130716
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationships of 5-substituted pyridine analogues of 3.
Lin NH; Li Y; He Y; Holladay MW; Kuntzweiler T; Anderson DJ; Campbell JE; Arneric SP
Bioorg Med Chem Lett; 2001 Mar; 11(5):631-3. PubMed ID: 11266158
[TBL] [Abstract][Full Text] [Related]
18. Antagonism of nicotinic acetylcholine receptors by inhibitors of monoamine uptake.
López-Valdés HE; García-Colunga J
Mol Psychiatry; 2001 Sep; 6(5):511-9. PubMed ID: 11526465
[TBL] [Abstract][Full Text] [Related]
19. Conformationally restricted analogues of nicotine and anabasine.
Vernier JM; Holsenback H; Cosford ND; Whitten JP; Menzaghi F; Reid R; Rao TS; Sacaan AI; Lloyd GK; Suto CM; Chavez-Noriega LE; Washburn MS; Urrutia A; McDonald IA
Bioorg Med Chem Lett; 1998 Aug; 8(16):2173-8. PubMed ID: 9873508
[TBL] [Abstract][Full Text] [Related]
20. Differential inhibition of nicotine- and acetylcholine-evoked currents through alpha4beta2 neuronal nicotinic receptors by tobacco cembranoids in Xenopus oocytes.
Eaton MJ; Ospina CA; Rodríguez AD; Eterović VA
Neurosci Lett; 2004 Aug; 366(1):97-102. PubMed ID: 15265598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
